share_log

君圣泰医药-B(02511):决定将在河北省沧州渤海新区南大港产业园区设立生产原材料运营主体基地

Kunshengtai Medicine-B (02511): It has decided to establish a production raw material operation main base in Nandagang Industrial Park of Bohai New District, Cangzhou, Hebei Province.

Zhitong Finance ·  Jun 28 18:41

Junshengtai Medicine-B (02511) announced that, after negotiations with relevant regional government departments, the group has decided to establish a production material operation main base in Nandagang Industrial Park in Bohai New Area, Cangzhou City, Hebei Province.

Through business expansion plans, the group expects to make full use of local preferential policies, establish and improve the group's raw material production and supply capacity at a relatively low cost, and establish reliable strategic cooperation and partnership for the group's core products in China. The company believes that the above-mentioned business expansion plans are in line with the overall interests of the company and its shareholders.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment